Voir la vidéoWatch the full video
100
100

Management ownership 100%

1
1

Turnover billion €

5
5

World Top 5

6000
6000

Headcount

News
Delpharm continues its growth in Europe with the acquisition of state-of-the-art drug production facilities in the Netherlands, from Astellas.

World-leading CDMO Delpharm expands its pharmaceutical network with the acquisition from Astellas of the Meppel pharmaceutical manufacturing facility.

Prefilled syringes
With Delpharm Leiden development center and Tours experts, we can support you in the development and manufacture of prefilled syringes. We have the capacity to produce between 25 and 30 million syringes a year in sizes ranging from 1ml to 50ml.
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.
Read more...

Customer references

Takeda
Aguettant
Bracco
Biocodex
Boehringer Indelheim
Servier
Genfit
LFB
Merck
Bayer
Urgo
Aurobindo
Eisai
Zoetis
Zentiva
Sanionia
Meda
Sandoz
Daiichi-Sankyo
GlaxoSmithKline
Mylan
HRA Pharma
Teva
Biogaran
Cooper
Sanofi
OM Pharma
Novartis